MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment.
Puri BK, Bydder GM, Counsell SJ, Corridan BJ, Richardson AJ, Hajnal JV, Appel C, Mckee HM, Vaddadi KS, Horrobin DF.
Puri BK, et al. Among authors: counsell sj.
Neuroreport. 2002 Jan 21;13(1):123-6. doi: 10.1097/00001756-200201210-00029.
Neuroreport. 2002.
PMID: 11924873
Clinical Trial.
A 6-month randomized, placebo-controlled pilot study of the ethyl-ester of eicosapentaenoic acid (ethyl-EPA) was carried out in seven in-patients with advanced (stage III) Huntington's disease (three on ethyl-EPA, four on placebo; no significant difference in age or sex be …
A 6-month randomized, placebo-controlled pilot study of the ethyl-ester of eicosapentaenoic acid (ethyl-EPA) was carried out in seven …